Evidence map›Paper›PMID 38578498›Full record

ArticleJournal of neurology2024

A multimodal clinical diagnostic approach using MRI and

Anna Lavrova, Nha Trang Thu Pham, Cynthia J Vernon, Arenn F Carlos, Ronald C Petersen, Dennis W Dickson, Val J Lowe, Clifford R Jack, Jennifer L Whitwell, Keith A Josephs

Open access · greenAbstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. New criteria to predict LATE-NC in the clinical setting: Probable/Possible LATE and LANS.Journal of neuropathology and experimental neurology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Anna LavrovaDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0009-0001-7521-7082
Nha Trang Thu PhamDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Cynthia J VernonDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Arenn F CarlosDepartment of Neurology, College of Medicine and Science, 200 First Street S.W., Rochester, MN, 55905, USA.
Ronald C PetersenDepartment of Neurology, College of Medicine and Science, 200 First Street S.W., Rochester, MN, 55905, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Val J LoweDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Clifford R JackDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Jennifer L WhitwellDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Keith A JosephsDepartment of Neurology, College of Medicine and Science, 200 First Street S.W., Rochester, MN, 55905, USA. josephs.keith@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic · USMayo Clinic in Florida · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C · 1999 to 2018
$36.9M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2019 to 2026
$33.5M
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkersR37AG011378 · NIA · MAYO CLINIC ROCHESTER · PI CLIFFORD R. JACK · 2018 to 2026
$6.8M
Understanding the role of TDP-43 in Alzheimers disease and FTLDR01AG037491 · NIA · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2024
$6.5M
Stathmin-2 and TDP-43 neurodegeneration in Alzheimer’s and multi-etiology dementiasRF1NS120992 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Keith A Josephs, Mercedes Prudencio · 2021 to 2026
$4.2M
Stathmin-2 and TDP-43 neurodegeneration in Alzheimer’s and multi-etiology dementiasR01NS120992 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, PRUDENCIO, MERCEDES · 2024 to 2025
$1.6M
Foundation for the National Institutes of Health P50 AG16574Foundation for the National Institutes of Health R01 AG37491-10NIA NIH HHS P30 AG062677NIA NIH HHS P50 AG016574NIA NIH HHS R01 AG037491NIA NIH HHS R37 AG011378NIA NIH HHS U01 AG006786NINDS NIH HHS R01 NS120992NINDS NIH HHS RF1 NS120992
6 · The paper itself

Abstract

objectiveTo evaluate the utility of clinical assessment scales for MRI and

methodsWe conducted a cross-sectional analysis on patients with antemortem MRI and

resultsOf the 64 cases in the study, 20 (31%) were TDP-43 ( +), of which 12 (60%) were female. TDP-43 ( +) cases were more likely to have hippocampal sclerosis (HS) (p = 0.014) and moderate-severe medial temporal lobe atrophy on MRI (p = 0.048). TDP-43( +) cases also showed a trend for less parietal atrophy on MRI (p = 0.086) and more medial temporal lobe hypometabolism on

conclusionVisual inspection of the medial temporal lobe on MRI and FDG-PET may help to predict TDP-43 status in the context of low-intermediate ADNC and PART.

Indexed as

Alzheimer DiseaseDNA-Binding ProteinsFluorodeoxyglucose F18Magnetic Resonance ImagingPositron-Emission TomographyTauopathiesAgedAged, 80 and overBrainCross-Sectional StudiesFemaleHumansMaleMiddle AgedMultimodal ImagingTDP-43 ProteinopathiesDNA-Binding ProteinsFluorodeoxyglucose F18TARDBP protein, human18F-FDG-PETLATEMRIPrimary age-related tauopathyTAR DNA-binding protein 43

Identifiers

PMID38578498
PMCPMC11233234
OpenAlexW4393993794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.